Plasma ctDNA, CTCs, and exosomal miRNAs has achieved promising diagnostic accuracy over cancer antigen 125 (CA125) in small groups of patients with ovarian cancer, among which ctDNA demonstrates the highest accuracy. Here, MUC16 is linked to ovarian carcinoma.